SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the ...

SciSparc (SPRC)announced that on September 16, 2025 the board of directors resolved to initiate the launch of an innovative initiative to advance ...

Investing.com -- SciSparc Ltd. (NASDAQ:SPRC) stock rose 2.6% on Thursday after the clinical-stage pharmaceutical company announced plans to launch a new initiative focused on 3D protein modeling using ...

A researcher has proposed a more targeted approach to AI drug discovery, which includes a rigorous evaluation protocol.

Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...

Objectives Patients with primary Sjögren’s disease (SjD) have an increased risk of B cell lymphoma. The aim of this study was ...

UNESCO For Women in Science honour. Her larger vision is to inspire young girls to break the glass ceiling in science.

SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced three abstracts from its clinical development programs will be presented at the upcoming ...

Southern India's cicadas orchestrate a stunning dawn chorus, beginning precisely at civil twilight. Thousands of these ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced positive topline ...

Objective Small fibre neuropathy (SFN) is an under-recognised complication of SLE that contributes to chronic pain and ...

Innovation is rapidly transforming the canned wet cat food segment. Leading manufacturers and emerging players alike are ...